Clinical Trial News and Research

RSS
Positive results from Intercept OCA Phase II trial in patients with PBC

Positive results from Intercept OCA Phase II trial in patients with PBC

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Alnylam completes patient enrollment in ALN-VSP Phase I trial against liver cancer

Sinovac reports fourth quarter net sales of $9.1 million

Sinovac reports fourth quarter net sales of $9.1 million

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

Vanda to initiate tasimelteon Phase IIb/III clinical trial in Major Depressive Disorder

RXi Pharmaceuticals to acquire Apthera

RXi Pharmaceuticals to acquire Apthera

Adeona reports $3,164,512 net revenue for 2010

Adeona reports $3,164,512 net revenue for 2010

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

Positive top-line data from Inhibitex INX-189 Phase 1b trial against HCV

SMFM praises FDA's announcement on Makena drug

SMFM praises FDA's announcement on Makena drug

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

CEL-SCI to initiate Multikine Phase III trial against head and neck cancer in Israel

Low doses of estrogen, growth hormone can increase height in girls with Turner syndrome

Low doses of estrogen, growth hormone can increase height in girls with Turner syndrome

XTRAC laser therapy can offer relief to patients with severe psoriasis

XTRAC laser therapy can offer relief to patients with severe psoriasis

Columbia Labs' PROCHIEVE Phase III trial results to be published in online medical journal

Columbia Labs' PROCHIEVE Phase III trial results to be published in online medical journal

FDA grants orphan drug status to America Stem Cell's ASC-101

FDA grants orphan drug status to America Stem Cell's ASC-101

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

SLN to present Atu027 Phase I study data against solid cancer at ASCO Annual Meeting

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

Positive preliminary results from Presidio's PPI-461 Phase 1b trial against HCV

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

BIOTRONIK completes patient enrollment in IN-TIME clinical trial to treat HF

Researchers develop new drug for multiple cancer treatment

Researchers develop new drug for multiple cancer treatment

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Intercept initiates OCA FLINT trial in patients with nonalcoholic steatohepatitis

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Metabolic Solutions initiates MSDC-0602 Phase 2a trial in patients with type 2 diabetes

Oral antioxidant formulation before medical imaging may minimize cell damage

Oral antioxidant formulation before medical imaging may minimize cell damage

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.